European Journal of Pharmacology · 2023 · 10 citations · 63 references
Life SciencesMolecular BiologyOncologyCancer PharmacologyGene ExpressionMolecular OncologyCancer MetabolismCancer TranscriptomicsEpigenetic Regulation In CancerFructose MetabolismMetabolic ReprogrammingMetabolic Reprogramming In CancerFructose AbsorptionFructose Metabolism RegulationFructose TransportersGlucose Transporter 5Histone Deacetylase TargetsIntestinal Fructose Transport
GLUT5, a key protein encoded by the SLC2A5 gene, is involved in the uptake of fructose from the intestine. Currently, with the increased consumption of this sugar and the associated increased incidence of obesity, diabetes and cancer, GLUT5 may represent an important molecular target in the prevention and treatment of these diseases. Here, we demonstrate that overexpression of the SNAI1 and SNAI2 transcription factors in cells expressing high levels of SLC2A5 mRNA reduced SLC2A5 gene expression. Furthermore, a histone deacetylase inhibitor, trichostatin A, which induces SNAI1 and SNAI2 expression, inhibits SLC2A5/GLUT5 expression and sensitizes colon cancer cells to cisplatin and oxaliplatin. This finding might have potential relevance for the development of therapeutic treatments aimed at modulating fructose transport or genes involved in this process for use with certain cancers.
63
The consensus molecular subtypes of colorectal cancer
Justin Guinney, Rodrigo Dienstmann, Xin Wang et al. · Nature Medicine · 2015 · 5.3K citations · Full text